Contact Us
Acute Lung Injury Global Market Report 2025
Global Acute Lung Injury Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Acute Lung Injury Global Market Report 2025

By Injury Type (Direct Injury, Indirect Injury), By Therapy (Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies ), By End User (Hospitals, Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Acute Lung Injury Market Overview

• Acute Lung Injury market size has reached to $2.48 billion in 2024

• Expected to grow to $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%

• Growth Driver: Rising Prevalence Of Respiratory Diseases Are Driving The Growth Of The Market

• Market Trend: Advancements In Acute Lung Injury Enhanced Market Growth

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Acute Lung Injury Market?

Acute lung injury (ALI) is a severe condition characterized by widespread inflammation and damage to the lungs, leading to impaired oxygen exchange. It is often triggered by direct factors such as pneumonia or trauma, or indirect causes such as sepsis or pancreatitis. ALI results in symptoms such as shortness of breath, low oxygen levels, and respiratory distress.

The main types of acute lung injury are direct injury and indirect injury. A direct injury refers to harm or damage that occurs as a direct result of an action, event, or incident. Therapy options include mechanical ventilation, pharmacotherapy, fluid management, and others and are utilized by various end users, including hospitals, clinics, and others.

Acute Lung Injury Market Size and growth rate 2025 to 2029: Graph

What Is The Acute Lung Injury Market Size 2025 And Growth Rate?

The acute lung injury market size has grown steadily in recent years. It will grow from $2.48 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to awareness campaigns, increase in ICU admissions, smoking and air pollution, hospital-acquired infections, and mortality rate reduction efforts.

What Is The Acute Lung Injury Market Growth Forecast?

The acute lung injury market size is expected to see steady growth in the next few years. It will grow to $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to biologics and gene therapies, government funding and grants, the development of precision medicine, regenerative medicine and stem cell therapies, and global health policy reforms. Major trends in the forecast period include development of biologic drugs, wearable and remote monitoring devices, inhalation-based therapies, CRISPR and gene editing technologies and biosensors for real-time analysis.

The forecast of 4.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. may experience shortages in life-saving care as tariffs inflate the cost of mechanical ventilators and surfactant therapies manufactured in Switzerland and Canada, compromising ICU capacity and patient outcomes. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Acute Lung Injury Market Segmented?

1) By Injury Type: Direct Injury, Indirect Injury

2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis

What Is Driving The Acute Lung Injury Market? Rising Prevalence Of Respiratory Diseases Are Driving The Growth Of The Market

The rising prevalence of respiratory diseases is expected to propel the growth of the acute lung injury market going forward. Respiratory diseases refer to a group of conditions that affect the lungs and other parts of the respiratory system, leading to difficulty in breathing and impaired lung function. The rising prevalence of respiratory diseases can be due to increased air pollution, smoking, sedentary lifestyles, aging populations, and the impact of viral infections. Respiratory diseases, such as pneumonia, cause acute lung injury by triggering severe inflammation and damaging the alveoli, leading to impaired gas exchange and respiratory distress. For instance, in September 2023, according to the Australian Bureau of Statistics, an Australia-based government agency, the death rate from influenza and pneumonia in the country rose from 31.9 per 100,000 people in 2021 to 42.6 per 100,000 people in 2022, reflecting a substantial increase of approximately 33.54%. Therefore, the rising prevalence of respiratory diseases is driving the growth of the acute lung injury industry.

Who Are The Major Players In The Global Acute Lung Injury Market?

Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.

What Are The Key Trends Of The Global Acute Lung Injury Market? Advancements In Acute Lung Injury Enhanced Market Growth

Major companies operating in the acute lung injury market are focusing on developing novel treatments, such as peptide treatments, to sustain their position in the market. Peptide treatment refers to the use of short chains of amino acids (peptides) as therapeutic agents to treat medical conditions. For instance, in November 2022, Zuventus Healthcare Ltd., an Indian-based healthcare company, launched Aviptadil for treating acute respiratory distress syndrome (ARDS). This treatment offers several unique benefits, including potent vasodilatory properties that are 50 times more effective than prostacyclin, a lung protection mechanism that promotes surfactant production by binding to alveolar type II cells, anti-inflammatory effects that inhibit pro-inflammatory cytokines like IL-6 and TNF-alpha, and immunomodulatory action to regulate immune responses in the lungs. Aviptadil has also shown clinical efficacy in improving outcomes for patients with severe viral-related ARDS.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Acute Lung Injury Market? Ligand Pharmaceuticals Acquired Apeiron Biologics AG Expanding Oncology And Immuno-Oncology Portfolio

In September 2024, Ligand Pharmaceuticals Inc., a US-based biopharmaceutical company, acquired Apeiron Biologics AG for $100 million. The acquisition of Apeiron enhances Ligand's portfolio by incorporating innovative therapies, especially in immunotherapy and cancer treatment. It also broadens Ligand's research and development capabilities, creating potential for new revenue opportunities and reinforcing its position in the biotech industry. Apeiron Biologics AG is an Austria-based biotechnology company actively involved in developing treatments for acute lung injury (ALI).

What Is The Regional Outlook For The Global Acute Lung Injury Market?

North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Lung Injury Market?

The acute lung injury market consists of revenues earned by entities by providing services such as intensive care unit (ICU) care, mechanical ventilation, oxygen therapy, extracorporeal membrane oxygenation, and pulmonary rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute lung injury market also includes sales of mechanical ventilators, oxygen therapy products, inhaled medications, sedation and analgesics, and diuretics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Acute Lung Injury Industry?

The acute lung injury market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acute lung injury industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Acute Lung Injury Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.59 billion
Revenue Forecast In 2034 $3.07 billion
Growth Rate CAGR of 4.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The acute lung injury market covered in this report is segmented –
1) By Injury Type: Direct Injury, Indirect Injury
2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies
3) By End User: Hospitals, Clinics, Other End Users Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Acute Lung Injury Market Characteristics

3. Acute Lung Injury Market Trends And Strategies

4. Acute Lung Injury Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Acute Lung Injury Growth Analysis And Strategic Analysis Framework

5.1. Global Acute Lung Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Acute Lung Injury Market Growth Rate Analysis

5.4. Global Acute Lung Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Acute Lung Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Acute Lung Injury Total Addressable Market (TAM)

6. Acute Lung Injury Market Segmentation

6.1. Global Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Injury

Indirect Injury

6.2. Global Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mechanical Ventilation

Pharmacotherapy

Fluid Management

Other Therapies

6.3. Global Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.4. Global Acute Lung Injury Market, Sub-Segmentation Of Direct Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trauma-Induced Acute Lung Injury

Aspiration Pneumonitis

Pneumonia-Related Acute Lung Injury

Inhalation Injury

6.5. Global Acute Lung Injury Market, Sub-Segmentation Of Indirect Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sepsis-Related Acute Lung Injury

Shock-Induced Acute Lung Injury

Acute Lung Injury Due To Blood Transfusion

Acute Lung Injury Associated With Pancreatitis

7. Acute Lung Injury Market Regional And Country Analysis

7.1. Global Acute Lung Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Acute Lung Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Lung Injury Market

8.1. Asia-Pacific Acute Lung Injury Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Lung Injury Market

9.1. China Acute Lung Injury Market Overview

9.2. China Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Lung Injury Market

10.1. India Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Lung Injury Market

11.1. Japan Acute Lung Injury Market Overview

11.2. Japan Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Lung Injury Market

12.1. Australia Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Lung Injury Market

13.1. Indonesia Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Lung Injury Market

14.1. South Korea Acute Lung Injury Market Overview

14.2. South Korea Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Lung Injury Market

15.1. Western Europe Acute Lung Injury Market Overview

15.2. Western Europe Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Lung Injury Market

16.1. UK Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Lung Injury Market

17.1. Germany Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Lung Injury Market

18.1. France Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Lung Injury Market

19.1. Italy Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Lung Injury Market

20.1. Spain Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Lung Injury Market

21.1. Eastern Europe Acute Lung Injury Market Overview

21.2. Eastern Europe Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Lung Injury Market

22.1. Russia Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Lung Injury Market

23.1. North America Acute Lung Injury Market Overview

23.2. North America Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Lung Injury Market

24.1. USA Acute Lung Injury Market Overview

24.2. USA Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Lung Injury Market

25.1. Canada Acute Lung Injury Market Overview

25.2. Canada Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Lung Injury Market

26.1. South America Acute Lung Injury Market Overview

26.2. South America Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Lung Injury Market

27.1. Brazil Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Lung Injury Market

28.1. Middle East Acute Lung Injury Market Overview

28.2. Middle East Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Lung Injury Market

29.1. Africa Acute Lung Injury Market Overview

29.2. Africa Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Lung Injury Market Competitive Landscape And Company Profiles

30.1. Acute Lung Injury Market Competitive Landscape

30.2. Acute Lung Injury Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Ono Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Acute Lung Injury Market Other Major And Innovative Companies

31.1. Aster DM Healthcare

31.2. Octapharma AG

31.3. Cartesian Therapeutics Inc.

31.4. Vapotherm Inc.

31.5. Stemedica Cell Technologies Inc.

31.6. Implicit Bioscience Ltd.

31.7. Apeiron Biologics AG

31.8. Faron Pharmaceuticals Ltd.

31.9. Histocell Sociedad Limitada

31.10. Vasomune Therapeutics Inc

31.11. Windtree Therapeutics Inc.

31.12. Qx Therapeutics Inc.

31.13. Asklepion Pharmaceuticals LLC

31.14. ReAlta Life Sciences Inc.

31.15. MediciNova Inc.

32. Global Acute Lung Injury Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Lung Injury Market

34. Recent Developments In The Acute Lung Injury Market

35. Acute Lung Injury Market High Potential Countries, Segments and Strategies

35.1 Acute Lung Injury Market In 2029 - Countries Offering Most New Opportunities

35.2 Acute Lung Injury Market In 2029 - Segments Offering Most New Opportunities

35.3 Acute Lung Injury Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Acute Lung Injury Market, Sub-Segmentation Of Direct Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Acute Lung Injury Market, Sub-Segmentation Of Indirect Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Acute Lung Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Acute Lung Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: GlaxoSmithKline plc Financial Performance
  • Table 78: Medtronic plc Financial Performance
  • Table 79: Baxter International Inc. Financial Performance
  • Table 80: Ono Pharmaceutical Co Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Acute Lung Injury Market, Sub-Segmentation Of Direct Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Acute Lung Injury Market, Sub-Segmentation Of Indirect Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Acute Lung Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Acute Lung Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Acute Lung Injury Market, Segmentation By Injury Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Acute Lung Injury Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Acute Lung Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: GlaxoSmithKline plc Financial Performance
  • Figure 78: Medtronic plc Financial Performance
  • Figure 79: Baxter International Inc. Financial Performance
  • Figure 80: Ono Pharmaceutical Co Ltd. Financial Performance

Frequently Asked Questions

Acute lung injury (ALI) is a severe condition characterized by widespread inflammation and damage to the lungs, leading to impaired oxygen exchange. It is often triggered by direct factors such as pneumonia or trauma, or indirect causes such as sepsis or pancreatitis. ALI results in symptoms such as shortness of breath, low oxygen levels, and respiratory distress. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Respiratory Diseases Are Driving The Growth Of The Market. For further insights on this market, request a sample here

The acute lung injury market size has grown steadily in recent years. It will grow from $2.48 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to awareness campaigns, increase in ICU admissions, smoking and air pollution, hospital-acquired infections, and mortality rate reduction efforts. The acute lung injury market size is expected to see steady growth in the next few years. It will grow to " $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to biologics and gene therapies, government funding and grants, the development of precision medicine, regenerative medicine and stem cell therapies, and global health policy reforms. Major trends in the forecast period include development of biologic drugs, wearable and remote monitoring devices, inhalation-based therapies, CRISPR and gene editing technologies and biosensors for real-time analysis. For further insights on this market, request a sample here

The acute lung injurymarket covered in this report is segmented –
1) By Injury Type: Direct Injury; Indirect Injury
2) By Therapy: Mechanical Ventilation; Pharmacotherapy; Fluid Management; Other Therapies
3) By End User: Hospitals; Clinics; Other End Users Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury; Aspiration Pneumonitis; Pneumonia-Related Acute Lung Injury; Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury; Shock-Induced Acute Lung Injury; Acute Lung Injury Due To Blood Transfusion; Acute Lung Injury Associated With Pancreatitis For further insights on this market,
request a sample here

North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc. . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Acute Lung Injury Enhanced Market Growth. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon